Stock listing
BX Swiss:ABG Cencora, Inc. Aktie
Swiss listing (BX Swiss) of Cencora, Inc. · home listing NYSE:COR
Follow Cencora, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:COR
$339.09 USD -9.22 (-2.6%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:COR
- Day range
- $337.88 – $348.57 USDNov 20, 2026
- Volume
- 1.23M sharesNov 20, 2026
- Market cap
- $64.71B USDAt the close on Nov 20, 2026 · price × 190.8M shares outstanding
- 52-week range
- $244.82 – $377.54 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $417.5M USDMedian day 1.11M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:COR · Home | $339.09 USD | -9.22 (-2.6%) | 1,231,459 | $344.31 | $348.57 | $337.88 | $348.31 | Close on Nov 20, 2026 |
| LSE:0HF3 | $348.60 USD | -2.77 (-0.8%) | 30 | $348.50 | $351.89 | $344.72 | $351.37 | Close on Nov 18, 2026 |
| B3:C1CO34 | 775.73 BRL | 0.00 (0.0%) | — | 775.73 | 775.73 | 775.73 | 775.73 | Close on Nov 19, 2026 |
| Frankfurt:ABG | €307.30 EUR | -7.40 (-2.4%) | — | €307.30 | €307.30 | €307.30 | €314.70 | Close on Nov 20, 2026 |
| Dusseldorf:ABG | €311.00 EUR | +0.70 (+0.2%) | — | €310.50 | €312.60 | €310.50 | €310.30 | Close on Nov 20, 2026 |
| Munich:ABG | €311.35 EUR | -7.90 (-2.5%) | — | €311.35 | €311.35 | €311.35 | €319.25 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:COR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $339.09 | -9.22 | -2.6% | $344.31 | $348.57 | $337.88 | 1,231,459 | |
| $348.31 | -2.25 | -0.6% | $347.16 | $349.80 | $344.49 | 1,204,991 | |
| $350.56 | -6.38 | -1.8% | $353.05 | $357.28 | $349.70 | 1,250,560 | |
| $356.94 | -2.09 | -0.6% | $362.59 | $363.31 | $355.90 | 1,029,380 | |
| $359.03 | +9.65 | +2.8% | $351.12 | $359.39 | $350.11 | 1,358,586 | |
| $349.38 | -0.50 | -0.1% | $352.95 | $354.84 | $348.68 | 997,506 | |
| $349.88 | +1.17 | +0.3% | $345.67 | $350.17 | $345.35 | 845,428 | |
| $348.71 | +2.95 | +0.9% | $347.00 | $350.17 | $342.60 | 1,071,188 | |
| $345.76 | +12.20 | +3.7% | $338.58 | $347.41 | $336.55 | 1,942,671 | |
| $333.56 | -6.12 | -1.8% | $333.61 | $338.54 | $333.05 | 1,584,010 | |
| $339.68 | -14.32 | -4.0% | $359.87 | $363.95 | $337.55 | 2,441,785 | |
| $354.00 | +13.50 | +4.0% | $342.20 | $355.64 | $336.72 | 2,887,379 | |
| $340.50 | +2.66 | +0.8% | $335.90 | $342.09 | $334.31 | 1,647,541 | |
| $337.84 | +7.00 | +2.1% | $333.26 | $338.16 | $329.15 | 1,506,754 | |
| $330.84 | +0.31 | +0.1% | $336.79 | $340.19 | $330.20 | 1,347,640 | |
| $330.53 | +6.18 | +1.9% | $328.84 | $331.07 | $326.34 | 1,025,200 | |
| $324.35 | -1.02 | -0.3% | $321.82 | $327.43 | $320.06 | 1,076,700 | |
| $325.37 | -4.63 | -1.4% | $327.77 | $330.15 | $325.00 | 1,123,100 | |
| $330.00 | -1.00 | -0.3% | $331.60 | $335.45 | $329.17 | 993,500 | |
| $331.00 | -7.48 | -2.2% | $337.15 | $338.07 | $330.31 | 1,168,300 | |
| $338.48 | -1.95 | -0.6% | $344.43 | $344.43 | $337.11 | 1,183,200 | |
| $340.43 | -2.84 | -0.8% | $343.05 | $344.44 | $338.34 | 1,514,600 | |
| $343.27 | +3.27 | +1.0% | $343.50 | $345.00 | $339.53 | 916,800 | |
| $340.00 | -0.92 | -0.3% | $338.13 | $342.18 | $336.47 | 1,031,400 | |
| $340.92 | -0.49 | -0.1% | $343.31 | $343.31 | $339.01 | 1,978,900 | |
| $341.41 | +5.24 | +1.6% | $342.70 | $345.46 | $339.26 | 1,589,600 | |
| $336.17 | +6.06 | +1.8% | $332.08 | $336.33 | $330.82 | 1,187,000 | |
| $330.11 | +5.05 | +1.6% | $328.07 | $331.60 | $327.11 | 1,113,800 | |
| $325.06 | +1.21 | +0.4% | $325.37 | $327.96 | $323.64 | 959,200 | |
| $323.85 | +2.50 | +0.8% | $319.50 | $325.82 | $318.79 | 781,900 | |
| $321.35 | +4.10 | +1.3% | $316.59 | $322.58 | $314.90 | 897,578 | |
| $317.25 | +0.88 | +0.3% | $317.30 | $322.41 | $315.15 | 1,060,756 | |
| $316.37 | +1.44 | +0.5% | $314.63 | $316.44 | $311.83 | 817,905 | |
| $314.93 | +5.88 | +1.9% | $309.43 | $316.06 | $307.87 | 1,148,053 | |
| $309.05 | -0.73 | -0.2% | $308.29 | $310.43 | $302.14 | 1,164,367 | |
| $309.78 | +9.53 | +3.2% | $303.18 | $313.02 | $300.77 | 1,889,580 | |
| $300.25 | -7.35 | -2.4% | $306.40 | $306.40 | $295.01 | 1,811,105 | |
| $307.60 | +3.79 | +1.2% | $300.00 | $307.62 | $298.21 | 1,268,388 | |
| $303.81 | -3.11 | -1.0% | $306.20 | $307.94 | $302.84 | 1,521,363 | |
| $306.92 | -2.95 | -1.0% | $308.95 | $310.89 | $304.31 | 1,084,057 | |
| $309.87 | -2.41 | -0.8% | $313.32 | $316.61 | $309.18 | 1,081,436 | |
| $312.28 | -2.15 | -0.7% | $315.51 | $320.24 | $310.71 | 1,103,059 | |
| $314.43 | -2.06 | -0.7% | $317.62 | $320.00 | $313.89 | 775,721 | |
| $316.49 | +7.71 | +2.5% | $309.74 | $316.98 | $308.51 | 1,049,948 | |
| $308.78 | -0.63 | -0.2% | $307.42 | $311.81 | $304.45 | 3,344,625 | |
| $309.41 | -9.09 | -2.9% | $318.36 | $319.77 | $309.24 | 1,098,496 | |
| $318.50 | -4.79 | -1.5% | $321.83 | $323.98 | $317.97 | 931,141 | |
| $323.29 | -2.94 | -0.9% | $324.98 | $325.88 | $318.08 | 913,496 | |
| $326.23 | +4.66 | +1.4% | $325.64 | $327.79 | $322.46 | 1,063,973 | |
| $321.57 | +0.62 | +0.2% | $323.99 | $325.13 | $317.96 | 844,056 | |
| $320.95 | -2.37 | -0.7% | $326.34 | $327.90 | $320.91 | 1,346,332 | |
| $323.32 | -1.37 | -0.4% | $322.24 | $326.99 | $321.92 | 1,215,502 | |
| $324.69 | -6.26 | -1.9% | $327.55 | $330.00 | $323.05 | 2,200,493 | |
| $330.95 | -6.27 | -1.9% | $333.48 | $336.01 | $330.20 | 1,027,638 | |
| $337.22 | +0.86 | +0.3% | $337.90 | $338.71 | $334.87 | 1,085,311 | |
| $336.36 | +5.39 | +1.6% | $330.62 | $337.91 | $330.62 | 1,398,344 | |
| $330.97 | +7.37 | +2.3% | $325.97 | $331.65 | $325.92 | 1,518,597 | |
| $323.60 | +1.57 | +0.5% | $321.11 | $326.57 | $319.04 | 1,387,962 | |
| $322.03 | +0.80 | +0.2% | $322.30 | $323.74 | $320.39 | 628,857 | |
| $321.23 | -6.56 | -2.0% | $324.35 | $324.68 | $320.47 | 1,074,792 | |
| $327.79 | -0.27 | -0.1% | $328.39 | $331.00 | $326.30 | 841,574 | |
| $328.06 | +4.29 | +1.3% | $322.68 | $328.51 | $321.43 | 1,114,917 | |
| $323.77 | +5.73 | +1.8% | $317.76 | $324.58 | $317.65 | 760,395 | |
| $318.04 | +3.35 | +1.1% | $314.74 | $320.21 | $313.13 | 905,404 | |
| $314.69 | -2.41 | -0.8% | $314.77 | $318.23 | $312.61 | 1,175,755 |
Splits
3 splits since 1999 · NYSE:COR · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 2-for-1 | Split | |
| 2-for-1 | Split |
- Ticker
- BX Swiss:ABG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- BX Swiss
- Currency
- CHF
What changed lately
Latest news release · Nov 4, 2026
Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
Latest earnings call · Nov 4, 2026
Cencora (NYSE:COR) Q4 2026 Earnings Call
Replay and transcript
Latest deck · Nov 4, 2026
Q4 2026 Earnings Presentation
Earnings · 23 slides
Latest news
Cencora Reports Fiscal 2026 Fourth Quarter and Fiscal Year End Results
Nov 4, 2026
Closed $354.00 (+4.0%) on Nov 4, 2026
Cencora Announces New Organizational and Reporting Structure to Enhance Visibility and Focus
Nov 4, 2026
Closed $354.00 (+4.0%) on Nov 4, 2026
Cencora to Acquire American Oncology Network to Strengthen Support of Community Oncology
Oct 21, 2026
Closed $340.43 (-0.8%) on Oct 21, 2026
Cencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings Release
Oct 2, 2026
Closed $309.05 (-0.2%) on Oct 2, 2026
Cencora Elects Robert E. Sanchez to Its Board of Directors
Sep 25, 2026
Closed $306.92 (-1.0%) on Sep 25, 2026
Q3 2026 Cencora Earnings Presentation
Aug 5, 2026
Closed $317.22 (+3.6%) on Aug 5, 2026
Cencora Reports Fiscal 2026 Third Quarter Results
Aug 5, 2026
Closed $317.22 (+3.6%) on Aug 5, 2026
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
Jul 1, 2026
Closed $296.51 (+2.8%) on Jul 2, 2026
Cencora Announces Samantha Hammock as Chief Human Resources Officer
Jun 15, 2026
Closed $281.46 (0.0%) on Jun 16, 2026
Cencora to Support U.S. Distribution of Kite’s CAR T-Cell Therapies
Jun 2, 2026
Closed $264.84 (+0.1%) on Jun 2, 2026
Cencora, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 34 in the last 12 months · 52 in all · newest Nov 4, 2026 · oldest 2025
- Calls
- 50 calls with a replay · 50 with a transcript · latest Nov 4, 2026
- Decks
- 61 decks · latest Nov 4, 2026
Where Cencora, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:COR · Home listing | NYSE | United States | USD |
| gettex:ABG | gettex | Germany | EUR |
| Tradegate:ABG | Tradegate | Germany | EUR |
| VIE:ABC | Vienna | Austria | EUR |
| LS Exchange:766149 | LS Exchange | Germany | EUR |
| Lang & Schwarz:766149 | Lang & Schwarz | Germany | EUR |
| LSE:0HF3 | LSE | United Kingdom | USD |
| BMV:COR | BMV | Mexico | MXN |
| BOATS:COR | BOATS | United States | USD |
| Milan:1COR | Milan | Italy | EUR |
| B3:C1CO34 | B3 | Brazil | BRL |
| BIVA:COR | BIVA | Mexico | MXN |
| Frankfurt:ABG | Frankfurt | Germany | EUR |
| Stuttgart:ABG | Stuttgart | Germany | EUR |
| Dusseldorf:ABG | Dusseldorf | Germany | EUR |
| Munich:ABG | Munich | Germany | EUR |
| BX Swiss:ABG · This page | BX Swiss | Switzerland | CHF |
| Hamburg:ABG | Hamburg | Germany | EUR |
| Hanover:ABG | Hanover | Germany | EUR |
| Xetra:ABG | Xetra | Germany | EUR |
Valuation
P/E 24.6× against a median of 25.7×: 5th lowest of 11 Health care services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $73.62B USD
- P/E
- 24.6×
- EV/sales
- 0.2×
- EV/EBITDA
- 18.0×
- Price/book
- 21.2×
- Gross margin
- 4.0%
- Operating margin
- 0.9%
- Net margin
- 0.8%
- Debt to equity
- 3.8×
- Beta vs S&P 500
- 0.12
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cencora, Inc. · NYSE:COR | US$64.71B | US$73.62B | 24.6× | 0.2× | 18.0× | 21.2× | 0.8% | 3.8× | 0.12 |
| McKesson Corporation · NYSE:MCK | US$123.5B | US$126.2B | 26.3× | 0.3× | 18.0× | n/a | 1.1% | n/a | -0.11 |
| HCA Healthcare, Inc. · NYSE:HCA | US$99.34B | US$148.9B | 14.7× | 1.9× | n/a | n/a | 8.6% | n/a | 0.23 |
| Cardinal Health, Inc. · NYSE:CAH | US$63.17B | US$59.79B | 34.8× | 0.2× | 16.3× | n/a | 0.7% | n/a | 0.04 |
| Labcorp Holdings Inc. · NYSE:LH | US$29.81B | US$35.40B | 29.7× | 2.4× | n/a | 3.4× | 6.9% | 0.7× | 0.33 |
| Quest Diagnostics Incorporated · NYSE:DGX | US$28.42B | US$33.17B | 25.2× | 2.8× | 14.4× | 3.7× | 9.5% | 0.7× | -0.03 |
| Tenet Healthcare Corporation · NYSE:THC | US$21.19B | US$18.68B | 7.3× | 0.8× | 3.0× | 3.9× | 13.1% | 0.0× | 0.60 |
| IHH Healthcare Bhd. · MYX:IHH | US$16.98B | US$20.21B | 31.1× | 3.1× | 14.6× | 2.2× | 8.4% | 0.5× | n/a |
| Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP | US$14.28B | US$14.90B | 59.0× | 5.0× | 22.8× | 12.5× | 8.1% | 0.8× | n/a |
| Encompass Health Corporation · NYSE:EHC | US$13.19B | US$13.16B | 20.5× | 2.1× | n/a | 4.9× | 10.2% | 0.0× | 0.03 |
| Rede D'Or Sao Luiz SA · BMFBOVESPA:RDOR3 | US$13.12B | US$14.96B | 16.9× | 1.5× | 6.2× | 3.6× | 7.9% | 2.5× | n/a |
| Median of the others | US$24.80B | US$26.69B | 25.7× | 2.0× | 14.6× | 3.7× | 8.2% | 0.7× | 0.04 |
Forecasts
7 strong buy · 3 buy · 4 hold · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.
- Price target
- 388.25 USD · Analysts' mean
- EPS, year to Sep 2027
- 19.64 · 9 analysts
- Revenue, year to Sep 2027
- 351.8B · 8 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Robert P. Mauch | President and Chief Executive Officer |
| Eva Boratto | Executive Vice President and Chief Financial Officer |
| Matt Glucksmann | SVP and President, Health Systems |
| Richard Tremonte | EVP and President, Global Specialty Pharmaceuticals and Operations |
| Tim Cernohous | Senior Vice President and President, Retail Pharmacy and Alternate Care |
| Elizabeth Campbell | Executive Vice President and Chief Legal Officer |
| Melissa O'Brien | Vice President, Investor Relations |
| François Mandeville | Executive Vice President and Chief Strategy and M&A Officer |
| Juan Guerra | Executive Vice President, Alliance Healthcare |
| Pawan Verma | Executive Vice President and Chief Data and Information Officer |
| Sam Hammock | Executive Vice President and Chief Human Resources Officer |
Board
| Director | Role |
|---|---|
| Robert E. Sanchez | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Cencora (NYSE:COR) Q4 2026 Earnings Call | Wed, Nov 04, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q3 2026 Earnings Call | Wed, Aug 05, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q2 2026 Earnings Call | Wed, May 06, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q1 2026 Earnings Call | Wed, Feb 04, 2026 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q4 2025 Earnings Call | Wed, Nov 05, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q3 2025 Earnings Call | Wed, Aug 06, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q2 2025 Earnings Call | Wed, May 07, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q1 2025 Earnings Call | Wed, Feb 05, 2025 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q4 2024 Earnings Call | Wed, Nov 06, 2024 · 8:30 AM ET | Replay |
| Cencora (NYSE:COR) Q3 2024 Earnings Call | Wed, Jul 31, 2024 · 8:30 AM ET | Replay |
All 50 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 4, 2026 · Before open | +4.0% |
| Q3 2026 | Aug 5, 2026 · Before open | +3.6% |
| Q2 2026 | May 6, 2026 · Before open | −17.4% |
| Q1 2026 | Feb 4, 2026 · Before open | −8.8% |
| Q4 2025 | Nov 5, 2025 · Before open | +2.8% |
| Q3 2025 | Aug 6, 2025 · Before open | −2.9% |
| Q2 2025 | May 7, 2025 · Before open | +4.7% |
| Q1 2025 | Feb 5, 2025 · Before open | +0.7% |
| Q4 2024 | Nov 6, 2024 | +5.9% |
| Q3 2024 | Jul 31, 2024 · Before open | +3.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2024 | May 1, 2024 · Before open | −4.1% |
| Q1 2024 | Jan 31, 2024 · Before open | +5.5% |
| Q4 2023 | Nov 2, 2023 · Before open | +2.6% |
| Q3 2023 | Aug 2, 2023 · Before open | +1.2% |
| Q2 2023 | May 2, 2023 · Before open | +1.4% |
| Q1 2023 | Feb 1, 2023 · Before open | −4.7% |
| Q4 2022 | Nov 3, 2022 · Before open | +2.0% |
| Q3 2022 | Aug 3, 2022 · Before open | −2.7% |
| Q2 2022 | May 4, 2022 · Before open | +4.0% |
| Q1 2022 | Feb 2, 2022 · Before open | −1.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2026 Earnings Presentation | Earnings | 23 slides | Nov 4, 2026 |
| Q3 2026 Earnings Presentation | Earnings | 18 slides | Aug 5, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 18 slides | May 6, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 20 slides | Feb 4, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 13 slides | Jan 12, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 24 slides | Nov 5, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 18 slides | Aug 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 18 slides | May 7, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 19 slides | Feb 5, 2025 |
| 43rd Annual J.P. Morgan Healthcare Conference (January 2025) | Conference | 15 slides | Jan 13, 2025 |
Show 50 decks
This page holds 50 of 61 decks. Open Decks
Financings
| Raise | Date |
|---|---|
| Public offering of senior notes Announced: Citigroup Global Markets Inc. +3 Dealers: Citigroup Global Markets Inc. (co-lead), J.P. Morgan Securities LLC (co-lead), BofA Securities, Inc. (co-lead), Wells Fargo Securities, LLC (co-lead) Use of proceeds: Repay amounts under the 364-Day Term Credit Agreement used to fund part of the OneOncology acquisition; any remainder for general corporate purposes | Feb 10, 2026 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 321.3B | 294.0B | 262.2B | 238.6B | 214.0B | 189.9B | 179.6B | 167.9B | 153.1B | 146.8B |
| Cost of revenue | 309.9B | 284.0B | 253.2B | 230.3B | 207.0B | 184.7B | 174.5B | 163.3B | 148.6B | 142.6B |
| Gross profit | 11.5B | 9.91B | 8.96B | 8.30B | 6.94B | 5.19B | 5.14B | 4.61B | 4.55B | 4.27B |
| Selling, general and administrative | 6.49B | 5.66B | 5.31B | 4.85B | 3.59B | 2.77B | 2.66B | 2.46B | 2.13B | 2.09B |
| Operating income | 2.63B | 2.18B | 2.34B | 2.37B | 2.35B | -5.14B | 1.11B | 1.44B | 1.06B | 1.53B |
| Depreciation and amortization | 1.05B | 1.09B | 963.9M | 693.9M | 505.2M | 391.1M | 462.4M | 465.1M | 397.6M | 364.7M |
| EBITDA | 3.68B | 3.27B | 3.30B | 3.06B | 2.86B | -4.74B | 1.57B | 1.91B | 1.46B | 1.89B |
| Interest expense | 419.8M | 248.7M | 275.6M | 232.0M | 182.5M | 158.5M | 195.5M | 189.6M | 149.0M | 144.3M |
| Income before tax | 2.26B | 2.00B | 2.16B | 2.18B | 2.22B | -5.29B | 967.1M | 1.18B | 917.9M | 1.39B |
| Income tax | 690.5M | 484.7M | 428.3M | 516.5M | 677.3M | -1.89B | 113.0M | -438.5M | 553.4M | -37.0M |
| Net income | 1.55B | 1.51B | 1.75B | 1.70B | 1.54B | -3.41B | 855.4M | 1.66B | 364.5M | 1.43B |
| Earnings per share, basic | 8.02 | 7.60 | 8.62 | 8.15 | 7.48 | -16.65 | 4.07 | 7.61 | 1.67 | 6.73 |
| Earnings per share, diluted | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 | -16.65 | 4.04 | 7.53 | 1.64 | 6.32 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.36B | 3.13B | 2.59B | 3.39B | 2.55B | 4.60B | 3.37B | 2.49B | 2.44B | 2.74B |
| Short-term investments | 0 | 372.9M | 26.1M | |||||||
| Receivables | 25.2B | 23.9B | 20.9B | 18.5B | 18.2B | 13.8B | 12.4B | 11.3B | 10.3B | 9.18B |
| Inventory | 20.5B | 19.0B | 17.5B | 15.6B | 15.4B | 12.6B | 11.1B | 11.9B | 11.5B | 10.7B |
| Current assets | 52.2B | 47.7B | 42.8B | 39.6B | 38.8B | 33.1B | 28.1B | 25.9B | 24.3B | 22.9B |
| Property, plant and equipment | 2.54B | 2.18B | 2.14B | 2.14B | 2.16B | 1.48B | 1.77B | 1.89B | 1.80B | 1.53B |
| Goodwill | 13.7B | 9.32B | 9.57B | 8.50B | 9.03B | 6.71B | 6.71B | 6.66B | 6.04B | 5.99B |
| Total assets | 76.6B | 67.1B | 62.6B | 56.6B | 57.3B | 44.3B | 39.2B | 37.7B | 35.3B | 33.6B |
| Accounts payable | 54.7B | 50.9B | 45.8B | 40.2B | 38.0B | 31.7B | 28.4B | 26.8B | 25.4B | 23.9B |
| Current liabilities | 57.8B | 54.3B | 48.8B | 43.5B | 41.4B | 33.9B | 29.6B | 27.9B | 26.8B | 25.3B |
| Long-term debt | 7.54B | 3.81B | 4.15B | 4.63B | 6.38B | 3.62B | 4.03B | 4.16B | 3.43B | 3.58B |
| Total debt | 7.66B | 4.39B | 4.79B | 5.70B | 6.68B | 4.12B | 4.17B | 177.5M | 3.44B | 4.19B |
| Total liabilities | 74.8B | 66.3B | 61.9B | 56.5B | 56.8B | 45.1B | 36.5B | 35.0B | 33.3B | 31.5B |
| Shareholders' equity | 1.51B | 645.9M | 522.0M | -211.6M | 223.4M | -1.02B | 2.88B | 2.93B | 2.06B | 2.13B |
| Shares outstanding | 193.9M | 194.9M | 200.8M | 206.2M | 208.1M | 204.2M | 206.8M | 213.2M | 218.0M | 220.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 3.88B | 3.48B | 3.91B | 2.70B | 2.67B | 2.21B | 2.34B | 1.41B | 1.50B | 3.18B |
| Capital spending | -668.0M | -487.2M | -458.4M | -496.3M | -438.2M | -369.7M | -310.2M | -336.4M | -466.4M | -464.6M |
| Free cash flow | 3.21B | 3.00B | 3.45B | 2.21B | 2.23B | 1.84B | 2.03B | 1.07B | 1.04B | 2.71B |
| Cash from investing | -4.98B | -618.1M | -2.60B | -368.4M | -6.14B | -379.9M | -375.8M | -1.11B | -498.0M | -3.17B |
| Cash from financing | 2.25B | -2.33B | -2.22B | -1.75B | 1.95B | -603.6M | -1.09B | -242.9M | -1.31B | 565.1M |
| Dividends paid | -437.1M | -416.2M | -398.8M | -391.7M | -366.6M | -343.6M | -339.0M | -333.0M | -320.3M | -288.5M |
| Share buybacks | -435.5M | -1.49B | -1.18B | -483.7M | -82.2M | -420.4M | -674.0M | -639.2M | -329.9M | -2.27B |
| Change in cash | 1.10B | 545.0M | -840.6M | 523.4M | -1.53B | 1.22B | 881.7M | 57.4M | -306.7M | 574.4M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 10, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 4, 2026 | Current report | SEC |
| 8-K · Current report | Nov 4, 2026 | Results | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 3, 2026 | Insider trade | SEC |
| 8-K · Current report | Oct 21, 2026 | Results | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 1, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 25, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Sep 17, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 16, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 11, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 4, 2026 | Other filings | SEC |
| 4 · Change in ownership | Sep 2, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 1, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 25, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 24, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 14, 2026 | Management or board change | SEC |
| 8-K · Current report | Aug 12, 2026 | Current report | SEC |
| 144 · Notice of proposed sale | Aug 6, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 5, 2026 | Results | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 30, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| 11-K · Annual report of an employee plan | Jun 18, 2026 | Annual report | SEC |
| 8-K · Current report | Jun 15, 2026 | Management or board change | SEC |
| 8-K · Current report | May 29, 2026 | Management or board change | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 4 · Change in ownership | May 28, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 2, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 23, 2026 | Current report | SEC |
| 8-K · Current report | Mar 17, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 6, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | Feb 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Feb 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Feb 18, 2026 | Other filings | SEC |
| 8-K · Current report | Feb 18, 2026 | Current report | SEC |
| 8-K · Current report | Feb 13, 2026 | Material contract | SEC |
| 424B2 · Prospectus | Feb 11, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 11, 2026 | Current report | SEC |
| FWP · Free writing prospectus | Feb 10, 2026 | Offer document | SEC |
| 424B5 · Prospectus | Feb 10, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 10, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Feb 4, 2026 | Quarterly report | SEC |
| 8-K · Current report | Feb 4, 2026 | Results | SEC |
| 3 · Initial statement of ownership | Jan 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 22, 2026 | Insider trade | SEC |
| ARS · Annual report to shareholders | Jan 22, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Jan 22, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jan 22, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jan 22, 2026 | Management or board change | SEC |
| 144 · Notice of proposed sale | Jan 20, 2026 | Other filings | SEC |
| 5 · Annual statement of ownership | Jan 16, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 16, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Dec 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 17, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 17, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 15, 2025 | Current report | SEC |
| 10-K · Annual report | Nov 25, 2025 | Annual report | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 12, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 6, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 5, 2025 | Results | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 21, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 20, 2025 | Other filings | SEC |
| 4 · Change in ownership | Oct 3, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Oct 3, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 1, 2025 | Other filings | SEC |
| 4 · Change in ownership | Sep 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 18, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Sep 16, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 9, 2025 | Material contract | SEC |
| 8-K · Current report | Sep 3, 2025 | Current report | SEC |
| 8-K · Current report | Aug 27, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 18, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2025 | Results | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 23, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 22, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 22, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 18, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 8-K · Current report | Jul 3, 2025 | Material contract | SEC |
| 4 · Change in ownership | Jul 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 24, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jun 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 18, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jun 18, 2025 | Other filings | SEC |
| 11-K · Annual report of an employee plan | Jun 17, 2025 | Annual report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 9, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jun 6, 2025 | Material contract | SEC |
| 3 · Initial statement of ownership | Jun 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 2, 2025 | Insider trade | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 144 · Notice of proposed sale | May 29, 2025 | Other filings | SEC |
| 8-K · Current report | May 28, 2025 | Management or board change | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 28, 2025 | Big-stake notice | SEC |
| CERT · Exchange's certificate of listing | May 27, 2025 | Other filings | SEC |
| 8-A12B · Registration of shares for listing on an exchange | May 22, 2025 | Other filings | SEC |
| 8-K · Current report | May 22, 2025 | Material contract | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 20, 2025 | Other filings | SEC |
| 8-K · Current report | May 19, 2025 | Current report | SEC |
| 424B2 · Prospectus | May 19, 2025 | Offer document | SEC |
| 144 · Notice of proposed sale | May 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 19, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
This page holds 200 of 1,009 filings. Open Filings
Cap table
Built by 6ix from Cencora, Inc.’s releases · as of Jul 31, 2026
- Common shares
- 190,827,165
- Fully diluted
- 190,827,165
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 190,827,165 | Jul 31, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Jul 31, 2026 | 190,827,165 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Lori J. Ryerkerk Other companies: International Paper Company (Director · Since at least Jul 17, 2026); Norfolk Southern Corporation (Director · Since at least Jan 28, 2025); Eaton Corporation, PLC (Director · Since at least Apr 22, 2020); Celanese Corporation (Chairman and CEO, Director · May 1, 2019 – Feb 28, 2024 · Past); Axalta Coating Systems Ltd. (Director · Oct 30, 2015 – Feb 21, 2019 · Past); Hess Corporation (Senior Vice President · Nov 5, 2008 – Feb 4, 2009 · Past) | Director · Since at least Jun 1, 2025 |
| Dermot Mark Durcan Other companies: Veoneer Inc (VNE) (Director · Jun 12, 2018 – Apr 1, 2022 · Past); Advanced Micro Devices Inc (Director · Oct 30, 2017 – May 8, 2024 · Past); Freescale Semiconductor Ltd (Director · Aug 13, 2014 – Dec 7, 2015 · Past); MWI Veterinary Supply Inc (Director · Mar 5, 2014 – Feb 23, 2015 · Past); Micron Technology, Inc. (Chief Executive Officer, Director · Feb 13, 2006 – Oct 19, 2016 · Past) | Director · Since at least Sep 8, 2015 |
| Frank K. Clyburn Other companies: Kailera Therapeutics, Inc. (Director · Since at least Apr 16, 2026); Revolution Medicines, Inc. (Director · Since at least Aug 5, 2024); International Flavors & Fragrances, Inc. (Chief Executive Officer · Feb 14, 2022 – Mar 1, 2024 · Past); DuPont de Nemours, Inc. (Director · Jun 1, 2019 – Apr 28, 2021 · Past); Merck & Company, Inc. (EVP & Pres ? Human Health · Jan 1, 2019 – Oct 30, 2021 · Past) | Director · Since at least Oct 1, 2024 |
| Gregory D Wasson Other companies: P3 Health Partners Inc. (Director · Since at least Feb 9, 2021); OptimizeRx Corporation (Director · Since at least Jul 21, 2020); PNC Financial Services Group, Inc. (the) (Director · Jul 2, 2015 – Oct 1, 2018 · Past); Verizon Communications Inc. (Director · Mar 1, 2013 – Mar 6, 2018 · Past); Walgreen Company (President and CEO, Director · Apr 11, 2006 – Nov 12, 2014 · Past) | Director · May 15, 2014 – May 15, 2014 · Past |
| Kathleen W Hyle Other companies: X-Energy, Inc. (Director · Since at least Apr 24, 2026); ADT Inc. (Director · Sep 28, 2012 – May 2, 2016 · Past); Bunge Limited (Director · Jul 2, 2012 – Mar 2, 2020 · Past); Constellation Energy Corporation (Senior Vice President · Nov 11, 2008 – Mar 12, 2012 · Past) | Director · May 13, 2010 – Mar 11, 2024 · Past |
| Lon R Greenberg Other companies: Essential Utilities, Inc. (Director · Jun 1, 2012 – Sep 30, 2017 · Past); Ameriprise Financial, Inc. (Director · Apr 25, 2012 – Apr 27, 2022 · Past); AmeriGas Partners L.P (Director · Mar 21, 2012 – Dec 21, 2015 · Past); UGI Corporation (Director · Jan 1, 2012 – Jan 20, 2016 · Past) | Director · Since at least May 16, 2013 |
| Lorence H Kim Other companies: Revolution Medicines, Inc. (Director · Since at least Jul 12, 2022); Cowen Group Inc (Director · Feb 15, 2022 – Mar 1, 2023 · Past); Moderna, Inc. (Chief Financial Officer · Dec 7, 2018 – Jun 2, 2020 · Past); Seres Therapeutics, Inc. (Director · Jun 25, 2015 – Jun 13, 2019 · Past) | Director · Since at least Oct 1, 2022 |
| Eva Boratto Other companies: Bath & Body Works, Inc. (Chief Financial Officer · Since at least Aug 1, 2023); United Parcel Service, Inc. (Director · Since at least Sep 10, 2020); CVS Health Corporation (EVP & CFO · Jul 10, 2013 – May 4, 2021 · Past) | Executive Vice President and Chief Financial Officer · Since at least Jun 29, 2026 |
| John Palumbo Other companies: DarioHealth Corp. (Chairman of the Board, Board Member · Since at least Apr 10, 2026); Lucid Diagnostics Inc. (Board Member · Since at least Sep 22, 2025) | Director · Apr 13, 2026 – Nov 5, 2026 · Past |
| Lauren M. Tyler Other companies: Centene Corporation (Director · Since Jun 19, 2026); Alleghany Corporation (Director · Jan 15, 2019 – Oct 19, 2022 · Past) | Director · Since at least Oct 1, 2023 |
All 47 people
| Person | Seat |
|---|---|
| Michael J Long Other companies: Mobix Labs, Inc. (Director · Since at least Jan 22, 2024); Arrow Electronics, Inc. (Executive Chairman, Director · Dec 31, 2005 – Mar 17, 2023 · Past) | Director · May 11, 2006 – Mar 5, 2023 · Past |
| Richard W Gochnauer Other companies: UGI Corporation (Director · Jan 20, 2011 – Jan 30, 2019 · Past); Essendant Inc (Chief Executive Officer, Director · Jan 1, 2009 – Mar 8, 2011 · Past) | Director · Sep 25, 2008 – Mar 11, 2024 · Past |
| Robert E. Sanchez Other companies: Ryder System, Inc. (Director · Since at least Feb 7, 2020); Texas Instruments Incorporated (Director · Since at least Jan 24, 2020) | Director · Since at least Sep 25, 2026 |
| Steven H Collis Other companies: Bausch + Lomb Corporation (Director · Since at least Jan 1, 2026); Elevance Health, Inc. (Director · Since at least Aug 1, 2025) | Executive Chairman, Director · Since at least Feb 1, 2006 |
| Charles H Cotros Other companies: Allied Waste Industries Inc (Director · May 25, 2006 – Dec 5, 2008 · Past) | Director · Jan 31, 2006 – Dec 7, 2012 · Past |
| Dennis M Nally Other companies: Morgan Stanley (Director · Since at least Oct 1, 2016) | Director · Since at least Jan 1, 2020 |
| Ellen Cooper Other companies: Lincoln National Corporation (Chairman, President & CEO, Director · Since at least Aug 6, 2012) | Director · Since at least Jan 20, 2026 |
| Henry Wadsworth McGee III Other companies: Tegna Inc (Director · Since at least Jun 29, 2015) | Director · Feb 1, 2006 – Mar 9, 2023 · Past |
| James F Cleary Jr Other companies: MWI Veterinary Supply Inc (President and CEO, Director · Sep 26, 2008 – Feb 23, 2015 · Past) | Chief Financial Officer · Since at least Mar 5, 2015 |
| J Lawrence Wilson Other companies: Cummins Inc. (Director · Mar 1, 2006 – Mar 2, 2009 · Past) | Director · Feb 1, 2006 – May 1, 2009 · Past |
| Joy Rowan Other companies: Merck & Company, Inc. (Senior Vice President of Sales · Apr 16, 2026 – Nov 5, 2026 · Past) | Senior Vice President of Sales · Apr 16, 2026 – Nov 5, 2026 · Past |
| Leslie Donato Other companies: Mallinckrodt Inc (Director · Since at least Jul 31, 2025) | Director · Aug 8, 2019 – Nov 5, 2026 · Past |
| Pawan Verma Other companies: Foot Locker Inc (EVP & Chief Info & Cust Conn · Aug 10, 2015 – Sep 28, 2020 · Past) | Executive Vice President and Chief Data and Information Officer · Since at least Oct 1, 2025 |
| Peyton Howell Other companies: Tandem Diabetes Care, Inc. (Director · Since at least Aug 3, 2020) | Executive Vice President · Feb 20, 2012 – Apr 4, 2018 · Past |
| Redonda Miller Other companies: Invivyd, Inc. (Director · Nov 19, 2021 – Jun 22, 2022 · Past) | Director · Since at least Jan 1, 2023 |
| Silvana Battaglia Other companies: Agilon Health, Inc. (Director · Since at least Jun 22, 2023) | Executive Vice President · Since at least May 16, 2019 |
| Sun Park Other companies: Tenet Healthcare Corporation (Executive Vice President & Chief Financial Officer · Since at least Jan 1, 2024) | Executive Vice President · May 20, 2016 – Nov 17, 2017 · Past |
| Dale Danilewitz | Executive Vice President · Nov 13, 2014 – May 23, 2019 · Past |
| Elizabeth Campbell | Executive Vice President · Since at least Nov 8, 2023 |
| François Mandeville | Executive Vice President and Chief Strategy and M&A Officer · Since at least Nov 5, 2026 |
| Gina Clark | Executive Vice President · Nov 13, 2014 – May 31, 2024 · Past |
| James Frary | Executive Vice President · Sep 23, 2010 – Nov 9, 2016 · Past |
| Jane E Md Henney | Director · Mar 1, 2021 – Mar 5, 2023 · Past |
| John G Chou | Executive Vice President · Nov 11, 2015 – Dec 20, 2021 · Past |
| Juan Guerra | Executive Vice President, Alliance Healthcare · Since at least Nov 4, 2026 |
| Lawrence Marsh | Executive Vice President · Nov 13, 2014 – Apr 29, 2016 · Past |
| Lazarus Krikorian | SVP & Chief Accounting Officer · Since at least Dec 5, 2014 |
| Matt Glucksmann | SVP and President, Health Systems · Since at least Nov 5, 2026 |
| Melissa O'Brien | Vice President, Investor Relations · Since at least Oct 2, 2026 |
| Michael D Dicandilo | Executive VP & CFO · Jan 30, 2006 – May 2, 2011 · Past |
| Richard Tremonte | EVP and President, Global Specialty Pharmaceuticals and Operations · Since at least Nov 4, 2026 |
| Robert P. Mauch | President and Chief Executive Officer · Since at least Nov 4, 2022 |
| Sam Hammock | Executive Vice President and Chief Human Resources Officer · Since at least Jun 15, 2026 |
| Terrance P Haas | Senior Vice President · Feb 8, 2006 – Feb 27, 2008 · Past |
| Tim Cernohous | Senior Vice President and President, Retail Pharmacy and Alternate Care · Since at least Nov 4, 2026 |
| Tim G Guttman | Chief Financial Officer · Feb 13, 2012 – Nov 9, 2018 · Past |
| Werner Baumann | Director · Since at least Oct 1, 2023 |
Log in to ask 6ix AI your own questions about Cencora, Inc.